Effects of ACE inhibitors, calcium antagonists, and other blood pressure-lowering drugs.
نویسندگان
چکیده
منابع مشابه
Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials.
BACKGROUND The benefits of reducing blood pressure on the risks of major cardiovascular disease are well established, but uncertainty remains about the comparative effects of different blood-pressure-lowering regimens. We aimed to estimate effects of strategies based on different drug classes (angiotensin-converting-enzyme [ACE] inhibitors, calcium antagonists, angiotensin-receptor blockers [AR...
متن کاملValue of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials.
OBJECTIVE To determine the average reduction in blood pressure, prevalence of adverse effects, and reduction in risk of stroke and ischaemic heart disease events produced by the five main categories of blood pressure lowering drugs according to dose, singly and in combination. DESIGN Meta-analysis of 354 randomised double blind placebo controlled trials of thiazides, beta blockers, angiotensi...
متن کاملAngiotensin Ii Receptor Blockers: an Overview
Blockage of the renin-angiotensin system (RAS) is now recognized as an effective approach to the treatment of hypertension and congestive heart failure. Today, it is possible to antagonize the effects of angiotensin II (AT-II) more specifically by blocking its receptors by using nonpeptide receptor antagonists. AT-II-receptor antagonists were developed as agents that would more completely block...
متن کاملNew modalities for treatment of diabetic nephropathy: a mini review
Background and aims: Diabetic nephropathy (DN) is the most common cause of end-stage renal failure which could increase the risk of cardiovascular disease and morbidity and mortality in patients. The aim of this study was to investigate new modalities for treatment of diabetic nephropathy. Methods:This study was a mini-review research to investigate drugs that are used for DN treatment. Resul...
متن کاملBlood pressure-lowering for secondary prevention of stroke: ACE inhibition is not the key.
The questions that need to be addressed in this debate are 3-fold. First, do antihypertensive agents, including angiotensin-converting enzyme (ACE) inhibitors, prevent recurrent stroke and other vascular events? Second, is this effect dependent on their blood pressure (BP)–lowering properties? And last, are potentially beneficial non-BP effects limited to ACE inhibitors? The answers are straigh...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Current hypertension reports
دوره 3 3 شماره
صفحات -
تاریخ انتشار 2001